These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24479686)

  • 21. Impact of glycation on structural and antioxidant function of human serum albumin: Relevance in diabetic complications.
    Raghav A; Ahmad J; Alam K
    Diabetes Metab Syndr; 2016; 10(2):96-101. PubMed ID: 26725383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-enzymatic glycation of human albumin does not alter its palmitate binding.
    Murtiashaw MH; Winterhalter KH
    Diabetologia; 1986 Jun; 29(6):366-70. PubMed ID: 3743922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of diabetes on the pharmacokinetic behavior of natural polyphenols.
    Xiao J; Högger P
    Curr Drug Metab; 2014 Jan; 15(1):23-9. PubMed ID: 24328692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycation of albumin and its implication in Diabetes: A comprehensive analysis using mass spectrometry.
    Kumari N; Bandyopadhyay D; Kumar V; Venkatesh DB; Prasad S; Prakash S; Krishnaswamy PR; Balaram P; Bhat N
    Clin Chim Acta; 2021 Sep; 520():108-117. PubMed ID: 34089724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of human serum albumin tertiary structure induced by glycation. Spectroscopic study.
    Szkudlarek A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J; Sułkowska A
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 153():560-5. PubMed ID: 26433342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal serum protein binding of acidic drugs in diabetes mellitus.
    Ruiz-Cabello F; Erill S
    Clin Pharmacol Ther; 1984 Nov; 36(5):691-5. PubMed ID: 6488690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of Specific Glycation Sites in Human Serum Albumin as Prospective Type 2 Diabetes Mellitus Biomarkers.
    Spiller S; Frolov A; Hoffmann R
    Protein Pept Lett; 2017; 24(10):887-896. PubMed ID: 28155619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production.
    Hunt JV; Bottoms MA; Mitchinson MJ
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):529-35. PubMed ID: 8484733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin.
    Bohney JP; Feldhoff RC
    Biochem Pharmacol; 1992 Apr; 43(8):1829-34. PubMed ID: 1575775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
    Neelofar KM; Ahmad J; Arif Z; Alam K
    Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential recognition of advanced glycation end products by serum antibodies and low-grade systemic inflammation in diabetes mellitus and its complications.
    Raghav A; Ahmad J; Alam K
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1884-1891. PubMed ID: 30009900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive overview of human serum albumin glycation in diabetes mellitus.
    Qiu HY; Hou NN; Shi JF; Liu YP; Kan CX; Han F; Sun XD
    World J Diabetes; 2021 Jul; 12(7):1057-1069. PubMed ID: 34326954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycation of plasma proteins in type II diabetes lowers the non-covalent interaction affinities for dietary polyphenols.
    Xie Y; Xiao J; Kai G; Chen X
    Integr Biol (Camb); 2012 May; 4(5):502-7. PubMed ID: 22418826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas.
    Tsuchiya S; Sakurai T; Sekiguchi S
    Biochem Pharmacol; 1984 Oct; 33(19):2967-71. PubMed ID: 6487349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D prevents glycation of proteins: an in vitro study.
    Iqbal S; Alam MM; Naseem I
    FEBS Lett; 2016 Aug; 590(16):2725-36. PubMed ID: 27364912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural modifications of human albumin in diabetes.
    Guerin-Dubourg A; Catan A; Bourdon E; Rondeau P
    Diabetes Metab; 2012 Apr; 38(2):171-8. PubMed ID: 22349032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities.
    Baraka-Vidot J; Guerin-Dubourg A; Dubois F; Payet B; Bourdon E; Rondeau P
    Biochim Biophys Acta; 2013 Jun; 1830(6):3532-41. PubMed ID: 23376313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.
    Matsuda R; Jobe D; Beyersdorf J; Hage DS
    J Chromatogr A; 2015 Oct; 1416():112-20. PubMed ID: 26381571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-enzymatic glycation enhances human serum albumin binding capacity to sodium fluorescein at room temperature: A spectroscopic analysis.
    Fatima S; Anwar T; Ahmad N; Islam A; Sen P
    Clin Chim Acta; 2017 Jun; 469():180-186. PubMed ID: 28412196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on human serum albumin influence on glycation of fibrinogen.
    Kielmas M; Szewczuk Z; Stefanowicz P
    Biochem Biophys Res Commun; 2013 Sep; 439(1):78-83. PubMed ID: 23958299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.